Skip to main content
Mehrdad Rezaee, MD, Cardiology, San Jose, CA, El Camino Health

MehrdadRezaeeMD

Cardiology San Jose, CA

Adult Congenital Heart Disease, Interventional Cardiology

Physician

Are you Dr. Rezaee?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 100 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Mehrdad Rezaee, MD is a cardiologist in San Jose, California. He is currently licensed to practice medicine in California. He is affiliated with O'Connor Hospital, Santa Clara Valley Medical Center, and Regional Medical Center of San Jose.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1997 - 2000
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1994 - 1997
  • Medical College of Wisconsin
    Medical College of WisconsinClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1997 - 2024
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts MyWay EHR, Allscripts, 2013
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Press Mentions

  • Cocoa Shown to Lower Blood Pressure, May Offer Treatment for Hypertension
    Cocoa Shown to Lower Blood Pressure, May Offer Treatment for HypertensionAugust 2nd, 2022
  • Office of Communications and Public Affairs
    Office of Communications and Public AffairsNovember 8th, 2021
  • Mynomx Announces Scientific Validation of Its Cardiometabolic Risk Engines for Assessing Risk of COVID-19 in Populations
    Mynomx Announces Scientific Validation of Its Cardiometabolic Risk Engines for Assessing Risk of COVID-19 in PopulationsJune 5th, 2020
  • Join now to see all

Professional Memberships

Other Languages

  • Farsi

Hospital Affiliations